Skip to main content
. 2020 Dec 21;12(1):e00284. doi: 10.14309/ctg.0000000000000284

Figure 5.

Figure 5.

Performance of the immunodiagnostic models with panels to detect gastric cancer. (a) Receiver operating characteristic curves for the training cohort by the LDA model and LR model. (b) Receiver operating characteristic curves for the validation cohort by the LDA model and LR model. aThe Fisher linear discriminant analysis (LDA) model with 5 anti-TAAs (TP53, SMARCB1, COPB1, SRSF2, and GNAS) entering the model. bThe backward stepwise conditional LR model with 5 anti-TAAs (GNAS, PBRM1, TP53, COPB1, and ACVR1B) entering the model. CI, confidence interval; LR, logistic regression; TAA, tumor-associated antigen.